Literature DB >> 22244461

The child as proband for future parental cardiometabolic disease: the 26-year prospective Princeton Lipid Research Clinics Follow-up Study.

John A Morrison1, Charles J Glueck, Ping Wang.   

Abstract

OBJECTIVE: To evaluate children's cardiovascular disease (CVD) risk factors as predictors of parents' subsequent CVD, type 2 diabetes mellitus (T2DM), and high blood pressure (HBP). STUDY
DESIGN: We conducted a 26-year prospective follow-up of 852 5- to 19-year-old black and white schoolchildren (mean age, 12 years; Lipid Research Clinics, 1973-8), and parents (mean age, 40 years) from 519 families in Princeton Schools, Cincinnati, Ohio. Schoolchildren were reassessed in the Princeton Follow-up study 1999-2003 at mean age 39 years; CVD, T2DM, and HBP history of their 1038 parents were reassessed by mean age 66 years. We assessed relationships of childhood risk factors with parental CVD, T2DM, and HBP. Child-probands identified with triglyceride (TG) levels, blood pressure, low-density lipoprotein cholesterol levels, body mass index (BMI), and glucose level greater than and high-density lipoprotein cholesterol levels less than established cutoff points.
RESULTS: Pediatric HBP (P=.006) and low high-density lipoprotein cholesterol (P=.018) were predictive of parental CVD at age ≤50 years. Pediatric HBP (P=.02) and high TG (P=.03) were predictive of parental CVD at age ≤60 years. Pediatric high TG (P=.009) and high low-density lipoprotein cholesterol (P=.04) were predictive of parental CVD by age 66 years. Pediatric high BMI (P=.0006) were predictive of parental T2DM. Pediatric high BMI (P=.003) and black race (P=.004) were predictive of parental HBP.
CONCLUSIONS: Pediatric risk factors identify families with parents at increased risk for CVD, T2DM, and HBP, emphasizing the usefulness of the child as proband. Copyright Â
© 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22244461      PMCID: PMC3307843          DOI: 10.1016/j.jpeds.2011.12.003

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  49 in total

1.  Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests.

Authors:  P Greenland; S C Smith; S M Grundy
Journal:  Circulation       Date:  2001-10-09       Impact factor: 29.690

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

3.  Serum lipids and lipoproteins in children from families with early coronary heart disease.

Authors:  I Tamir; Y Bojanower; O Levtow; D Heldenberg; Z Dickerman; B Werbin
Journal:  Arch Dis Child       Date:  1972-10       Impact factor: 3.791

4.  Screening for hyperlipidemia in childhood.

Authors:  H P Chase; R J O'Quin; D O'Brien
Journal:  JAMA       Date:  1974-12-16       Impact factor: 56.272

5.  Hyperlipemia in progeny of parents with myocardial infarction before age 50.

Authors:  C J Glueck; R W Fallat; R Tsang; C R Buncher
Journal:  Am J Dis Child       Date:  1974-01

6.  Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study.

Authors:  P H Davis; J D Dawson; W A Riley; R M Lauer
Journal:  Circulation       Date:  2001-12-04       Impact factor: 29.690

7.  Cholesterol among children of men with myocardial infarction.

Authors:  C H Hennekens; M J Jesse; B E Klein; J E Gourley; S Blumenthal
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

8.  Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Stephen Cook; Michael Weitzman; Peggy Auinger; Michael Nguyen; William H Dietz
Journal:  Arch Pediatr Adolesc Med       Date:  2003-08

9.  Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study.

Authors:  Olli T Raitakari; Markus Juonala; Mika Kähönen; Leena Taittonen; Tomi Laitinen; Noora Mäki-Torkko; Mikko J Järvisalo; Matti Uhari; Eero Jokinen; Tapani Rönnemaa; Hans K Akerblom; Jorma S A Viikari
Journal:  JAMA       Date:  2003-11-05       Impact factor: 56.272

10.  The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study.

Authors:  D S Freedman; W H Dietz; R Tang; G A Mensah; M G Bond; E M Urbina; S Srinivasan; G S Berenson
Journal:  Int J Obes Relat Metab Disord       Date:  2004-01
View more
  4 in total

1.  Family history of myocardial infarction, stroke and diabetes and cardiometabolic markers in children.

Authors:  Nina E Berentzen; Alet H Wijga; Lenie van Rossem; Gerard H Koppelman; Bo van Nieuwenhuizen; Ulrike Gehring; Annemieke M W Spijkerman; Henriëtte A Smit
Journal:  Diabetologia       Date:  2016-05-30       Impact factor: 10.122

2.  A double-blind randomized trial of fish oil to lower triglycerides and improve cardiometabolic risk in adolescents.

Authors:  Samuel S Gidding; Carol Prospero; Jobayer Hossain; Frances Zappalla; Prabhakaran Babu Balagopal; Bonita Falkner; Peter Kwiterovich
Journal:  J Pediatr       Date:  2014-07-07       Impact factor: 4.406

3.  Vascular function and stiffness: population epidemiology and concordance in Australian children aged 11-12 years and their parents.

Authors:  Freya K Kahn; Melissa Wake; Kate Lycett; Susan Clifford; David P Burgner; Greta Goldsmith; Anneke C Grobler; Katherine Lange; Michael Cheung
Journal:  BMJ Open       Date:  2019-07-04       Impact factor: 2.692

4.  Universal screening for cardiovascular disease risk factors in adolescents to identify high-risk families: a population-based cross-sectional study.

Authors:  Michael Khoury; Cedric Manlhiot; Don Gibson; Nita Chahal; Karen Stearne; Stafford Dobbin; Brian W McCrindle
Journal:  BMC Pediatr       Date:  2016-01-21       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.